2-bromopyridine;N-hydroxy-4-[[(1-methylbenzimidazol-2-yl)-pyridin-2-ylamino]methyl]benzamide;methane;1-methylbenzimidazol-2-amine;methyl 4-[[(1-methylbenzimidazol-2-yl)-pyridin-2-ylamino]methyl]benzoate;1-methyl-N-pyridin-2-ylbenzimidazol-2-amine
C72H76BrN17O4 — CID 162078967
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-bromopyridine;N-hydroxy-4-[[(1-methylbenzimidazol-2-yl)-pyridin-2-ylamino]methyl]benzamide;methane;1-methylbenzimidazol-2-amine;methyl 4-[[(1-methylbenzimidazol-2-yl)-pyridin-2-ylamino]methyl]benzoate;1-methyl-N-pyridin-2-ylbenzimidazol-2-amine
2-bromopyridine;N-hydroxy-4-[[(1-methylbenzimidazol-2-yl)-pyridin-2-ylamino]methyl]benzamide;methane;1-methylbenzimidazol-2-amine;methyl 4-[[(1-methylbenzimidazol-2-yl)-pyridin-2-ylamino]methyl]benzoate;1-methyl-N-pyridin-2-ylbenzimidazol-2-amine (PubChem CID 162078967) has the molecular formula C72H76BrN17O4 and a molecular weight of 1323.42 g/mol. Its IUPAC name is 2-bromopyridine;N-hydroxy-4-[[(1-methylbenzimidazol-2-yl)-pyridin-2-ylamino]methyl]benzamide;methane;1-methylbenzimidazol-2-amine;methyl 4-[[(1-methylbenzimidazol-2-yl)-pyridin-2-ylamino]methyl]benzoate;1-methyl-N-pyridin-2-ylbenzimidazol-2-amine.
Molecular Properties
| Compound Name | 2-bromopyridine;N-hydroxy-4-[[(1-methylbenzimidazol-2-yl)-pyridin-2-ylamino]methyl]benzamide;methane;1-methylbenzimidazol-2-amine;methyl 4-[[(1-methylbenzimidazol-2-yl)-pyridin-2-ylamino]methyl]benzoate;1-methyl-N-pyridin-2-ylbenzimidazol-2-amine |
|---|---|
| PubChem CID | 162078967 |
| Molecular Formula | C72H76BrN17O4 |
| Molecular Weight | 1323.42 g/mol |
| Exact Mass | 1321.54 |
| IUPAC Name | 2-bromopyridine;N-hydroxy-4-[[(1-methylbenzimidazol-2-yl)-pyridin-2-ylamino]methyl]benzamide;methane;1-methylbenzimidazol-2-amine;methyl 4-[[(1-methylbenzimidazol-2-yl)-pyridin-2-ylamino]methyl]benzoate;1-methyl-N-pyridin-2-ylbenzimidazol-2-amine |
| SMILES | Brc1ccccn1.C.C.C.COC(=O)c1ccc(CN(c2ccccn2)c2nc3ccccc3n2C)cc1.Cn1c(N(Cc2ccc(C(=O)NO)cc2)c2ccccn2)nc2ccccc21.Cn1c(N)nc2ccccc21.Cn1c(Nc2ccccn2)nc2ccccc21 |
| InChI | InChI=1S/C22H20N4O2.C21H19N5O2.C13H12N4.C8H9N3.C5H4BrN.3CH4/c1-25-19-8-4-3-7-18(19)24-22(25)26(20-9-5-6-14-23-20)15-16-10-12-17(13-11-16)21(27)28-2;1-25-18-7-3-2-6-17(18)23-21(25)26(19-8-4-5-13-22-19)14-15-9-11-16(12-10-15)20(27)24-28;1-17-11-7-3-2-6-10(11)15-13(17)16-12-8-4-5-9-14-12;1-11-7-5-3-2-4-6(7)10-8(11)9;6-5-3-1-2-4-7-5;;;/h3-14H,15H2,1-2H3;2-13,28H,14H2,1H3,(H,24,27);2-9H,1H3,(H,14,15,16);2-5H,1H3,(H2,9,10);1-4H;3*1H4 |
| InChIKey | ZCBUCUZMFJUMGR-UHFFFAOYSA-N |
| XLogP | 15.14 |
| TPSA | 243.00 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 20 |
| Rotatable Bonds | 12 |
| Heavy Atoms | 94 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1323.42 |
| LogP ≤ 5 | 15.14 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 20 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': '2-halo_pyridine', 'substructure': 'N/A'}, {'alert_name': 'hydroxamic_acid', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 162078967 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.